The branded generics market is expected to grow from US$ 235.86 billion in 2022 to US$ 414.99 billion by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
Branded generics are generic drugs that have been given a proprietary market name. They may be marketed in a similar way as branded drugs. Branded generic drugs attach proprietary names to generic drug molecules. Some branded generics are specially made as novel dosage forms of off-patent drugs, filling in a dosage gap while offering consumers a name that is likely easier to remember than the true generic name. Branded generics are a small but profitable segment of the pharmaceutical market. Branded generics go through the same FDA approval process as other generics after branded drug patents expire.
According to a report released by VOXEU, with healthcare budgets worldwide under pressure, switching to branded generics seems a natural cost saver. Branded generics are cheaper alternatives to branded medicines, offering efficiency gains to any healthcare system. For instance, in 2016, US$ 253 billion was generated by generic medicines accounting for one-quarter of a trillion dollars. Additionally, US$ 1.6 trillion in healthcare savings in the same year accounted for in the US healthcare system evaluating a 10-year saving due to the availability of low-cost generics.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Branded Generics Market: Strategic Insights
Market Size Value in US$ 235.86 Billion in 2022 Market Size Value by US$ 414.99 Billion by 2028 Growth rate CAGR of 9.9% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Branded Generics Market: Strategic Insights
| Market Size Value in | US$ 235.86 Billion in 2022 |
| Market Size Value by | US$ 414.99 Billion by 2028 |
| Growth rate | CAGR of 9.9% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The branded generics market is segmented based on therapeutic application, distribution channel, drug class, formulation type, and geography. By geography, the branded generics market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The branded generics market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, trends, technological advancements, and market dynamics, and the analysis of the competitive landscape of the globally leading market players.
The global branded generics market is majorly driven by the rising penetration of branded generics and increasing government initiatives for promoting branded generics. Additionally, encouraging utility of branded generics by healthcare providers and professionals is likely to emerge as a significant future trend in the market during the forecast period. However, poor clinical outcomes and adverse effects of generic medications in the global market are hampering the market growth.
Lucrative Regions in Branded Generics Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Penetration of Branded Generics
According to a report released by VOXEU, with healthcare budgets worldwide under pressure, switching to branded generics seems a natural cost saver. Branded generics are cheaper alternatives to branded medicines, offering efficiency gains to any healthcare system. For instance, in 2016, US$ 253 billion was generated by generic medicines accounting for one-quarter of a healthcare industry.
Further, the Association for Accessible Medicines report states that nearly 3.9 billion generic prescriptions were dispensed in 2016. Therefore, branded generics present a viable opportunity for potential growth for big pharma players. According to the published report by HSRII, the US is the largest pharmaceutical market in the world (US$ 325 billion), accounting for one-third of the global pharmaceutical market, with generics accounting for 84% in terms of sales volume and 28% in terms of sales value. Furthermore, branded generics utilization has increased among the population due to savings provided by the healthcare system and the ability to invest in tomorrow's new medicines. For instance, nearly 3.9 billion prescriptions dispensed in the US are for generics. Moreover, on average, in 2016, the use of generic medicines saved each state US$ 4.9 billion compared to the price of relevant branded medicines. This further means that Medicaid savings averaged US$ 744 million, and state Medicaid savings averaged US$ 1.5 billion per state. Such factors accelerate the demand for branded generics, fueling the overall market growth during the forecast period.
Therapeutic Application-Based Insights
Based on therapeutic application, the global branded generics market has been segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and others. In 2022, the others held the largest share of the market. However, the oncology segment is expected to grow at the fastest CAGR from 2022 to 2028.
Branded Generics Market, by Therapeutic Application – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Distribution Channel-Based Insights
Based on distribution channel, the branded generics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. The retail pharmacies segment is likely to hold the largest share of the market in 2022. Moreover, the online pharmacies segment is anticipated to register the highest CAGR in the market during the forecast period.
Drug Class-Based Insights
Based on drug class, the branded generics market is categorized into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptic, and others. The others segment is likely to hold the largest share of the market in 2022. However, the hormones segment is anticipated to register the highest CAGR in the market during the forecast period.
Formulation Type-Based Insights
Based on formulation type, the branded generics market is segmented into oral, parenteral, topical, and others. In 2022, the oral segment held the largest share of the market by formulation type. However, the parenteral segment is expected to grow at the fastest CAGR from 2022 to 2028.
Several companies adopt strategies such as product launches and approvals to expand their global footprints and product portfolios. Moreover, the branded generics market players focus on the partnership strategy to enlarge their clientele, allowing them to maintain their brand name globally. The market share is anticipated to flourish with market players' development of new innovative products. Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Bausch Health Companies Inc., Lupin, Sanofi, AstraZeneca Plc., Dr.Reddy’s Laboratories, Par Pharmaceuticals, Inc., Sandoz International GmbH, Aspen Holdings, and Hetero are among the leading companies operating in the global branded generics market.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Therapeutic Application, Distribution Channel, Drug Class, and Formulation Type
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules. Some branded generics are specially made as novel dosage forms of off-patent drugs, filling in a dosage gap while offering consumers a name that is likely easier to remember than the true generic name. Branded generics are a small, but profitable segment of the pharmaceutical market. Branded generics go through the same FDA approval process as other generics after branded drug patents expire.
The factors that are driving and restraining factors that will affect the branded generics market in the coming years. Growth of the global branded generics market is majorly driven by rising penetration of branded generics and increasing government initiatives for promoting branded generics. Additionally, encouraging utility of branded generics by healthcare providers and professionals is likely to emerge as a significant future trend in the market during the forecast period. However, poorer clinical outcomes and adverse effects of generic medications hamper the branded generics market growth.
The branded generics market majorly consists of the players such as Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Bausch Health Companies Inc., Lupin, Sanofi, AstraZeneca Plc., Dr.Reddy’s Laboratories, Par Pharmaceuticals, Inc., Sandoz International GmbH, Aspen Holdings, and Hetero amongst others.
The branded generics market, by therapeutical application, is bifurcated oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and others. In 2022, the others segment held the largest share of the market, by therapeutic application. However, the oncology segment is expected to witness growth in its demand at a fastest CAGR during 2022 to 2028.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Branded Generics Market – By Therapeutic Application
1.3.2 Global Branded Generics Market – By Distribution Channel
1.3.3 Global Branded Generics Market – By Drug Class
1.3.4 Global Branded Generics Market – By Formulation Type
1.3.5 Global Branded Generics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Branded Generics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Branded Generics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Penetration of Branded Generics
5.1.2 Increasing Government Initiatives for Promoting Branded Generics
5.2 Market Restraints
5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications
5.3 Market Opportunities
5.3.1 Product Differentiation
5.4 Future Trends
5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals
5.5 Impact Analysis
6. Branded Generics Market– Global Analysis
6.1 Global Branded Generics Market Revenue Forecast and Analysis
6.2 Global Branded Generics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Branded Generics Market – Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1.1 Teva Pharmaceuticals Industries Ltd.
6.7.1.2 Sandoz International GmbH
6.8 Market Share Analysis of Branded Generics Market
7. Global Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application
7.1 Overview
7.2 By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
7.6 Neurology
7.6.1 Overview
7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)
7.7 Gastrointestinal Diseases
7.7.1 Overview
7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.8 Dermatology Diseases
7.8.1 Overview
7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.9 Analgesics and Anti-Inflammatory
7.9.1 Overview
7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
7.10 Others
7.10.1 Overview
7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
8. Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel
8.1 Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
8.2 Hospital Pharmacies
8.2.1 Overview
8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.3 Retail Pharmacies
8.3.1 Overview
8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.4 Online Pharmacies
8.4.1 Overview
8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.5 Drug Stores
8.5.1 Overview
8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9. Branded Generics Market Analysis and Forecast to 2028 by Drug Class
9.1 Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
9.2 Alkylating Agents
9.2.1 Overview
9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.3 Antimetabolites
9.3.1 Overview
9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.4 Hormones
9.4.1 Overview
9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.5 Anti-hypertensive
9.5.1 Overview
9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.6 Lipid Lowering Drugs
9.6.1 Overview
9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.7 Anti-Depressants
9.7.1 Overview
9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.8 Anti-psychotics
9.8.1 Overview
9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.9 Anti-epileptic
9.9.1 Overview
9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.10 Others
9.10.1 Overview
9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
10. Global Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type
10.1 Overview
10.2 Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
10.3 Oral
10.3.1 Overview
10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)
10.4 Parenteral
10.4.1 Overview
10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
10.5 Topical
10.5.1 Overview
10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
11. Branded Generics Market Revenue and Forecasts to 2028 Geographical Analysis
11.1 North America: Branded Generics Market
11.1.1 Overview
11.1.2 North America: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.3 North America: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.1.4 North America: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.1.5 North America: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.1.6 North America: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.1.7 North America: Branded Generics Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.1.1 Overview
11.1.7.1.2 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.1.3 US: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.1.7.1.4 US: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.1.7.1.5 US: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.1.7.1.6 US: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.1.7.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.2.3 Canada: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.1.7.2.4 Canada: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.1.7.2.5 Canada: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.1.7.2.6 Canada: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.1.7.3 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.7.3.3 Mexico: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.1.7.3.4 Mexico: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.1.7.3.5 Mexico: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.1.7.3.6 Mexico: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.2 Europe: Branded Generics Market
11.2.1 Overview
11.2.2 Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.3 Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.4 Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.5 Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.6 Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)
11.2.7.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.2 Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.3 Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.4 Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.5 Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.1 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.2 France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.3 France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.4 France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.5 France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.1 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.2 UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.3 UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.4 UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.5 UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.1 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.2 Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.3 Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.4 Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.5 Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.1 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.2 Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.3 Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.4 Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.5 Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.1 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.4 Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.5 Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.3 Asia Pacific Branded Generics Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.3 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.4 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.5 Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.6 Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.1.3 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.1.4 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.1.5 Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.1.6 Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.2.1 Overview
11.3.7.2.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.2.3 China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.2.4 China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.2.5 China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.2.6 China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7.3 India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.3.1 Overview
11.3.7.3.2 India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.3.3 India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.3.4 India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.3.5 India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.3.6 India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.4.3 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.4.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.4.5 South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.4.6 South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7.5 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.5.3 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.5.4 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.5.5 Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.5.6 Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.3 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.6.4 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.6.5 Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.6 Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.4 Middle East & Africa: Branded Generics Market Revenue and Forecast To 2028
11.4.1 Overview
11.4.2 Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.4.3 Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.4.4 Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.4.5 Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.4.6 Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.4.7 Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)
11.4.7.1 UAE: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.1.1 Overview
11.4.7.1.2 UAE: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.4.7.1.3 UAE: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.4.7.1.4 UAE: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.4.7.1.5 UAE: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.4.7.1.6 UAE: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.4.7.2 Saudi Arabia: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.4.7.2.3 Saudi Arabia: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.4.7.2.4 Saudi Arabia: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.4.7.2.5 Saudi Arabia: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.4.7.2.6 Saudi Arabia: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.4.7.3 South Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.3.1 Overview
11.4.7.3.2 South Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.4.7.3.3 South Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.4.7.3.4 South Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.4.7.3.5 South Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.4.7.3.6 South Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.4.7.4 Rest of Middle the East and Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.4.7.4.3 Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)
11.4.7.4.4 Rest of Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)
11.4.7.4.5 Rest of Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)
11.4.7.4.6 Rest of Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)
11.5 South and Central America Branded Generics Market Revenue and Forecast to 2028
11.5.1 Overview
11.5.2 South & Central America Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.3 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.4 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.5 South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.5.6 South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.5.7 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
11.5.7.1 Argentina Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.5.7.1.1 Overview
11.5.7.1.2 Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.1.3 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.1.4 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.1.5 Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.5.7.1.6 Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2 Brazil: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2.1 Overview
11.5.7.2.2 Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.2.3 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.2.4 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.2.5 Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2.6 Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.5.7.3 Rest of South and Central America: Branded Generics Market– Revenue and Forecast to 2028 (USD Billion)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.3.3 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.3.4 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.3.5 Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.5.7.3.6 Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
12. Impact Of COVID-19 Pandemic on Branded Generics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 SAM: Impact Assessment of COVID-19 Pandemic
13. Branded Generics Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 MYLAN N.V.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bausch Health Companies Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Lupin
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ASTRAZENECA PLC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Dr. Reddy's Laboratories
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Par Pharmaceuticals, INC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sandoz International GMBH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Aspen Holdings
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Hetero
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 2. North America Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Billion)
Table 3. North America Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)
Table 4. North America Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 5. US Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 6. US Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 7. US Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 8. US Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 9. Canada: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 10. Canada Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 11. Canada Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 12. Canada Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 13. Mexico: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 14. Mexico Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 15. Mexico Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 16. Mexico Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 17. Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 18. Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 19. Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 20. Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 21. Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 22. Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 23. Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 24. Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 25. France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 26. France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 27. France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 28. France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 29. UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 30. UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 31. UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 32. UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 33. Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 34. Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 35. Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 36. Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 37. Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 38. Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 39. Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 40. Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 41. Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 42. Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 43. Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 44. Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 45. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).
Table 46. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 47. Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 48. Asia Pacific: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 49. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 50. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 51. Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 52. Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 53. China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 54. China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 55. China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 56. China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 57. India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 58. India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 59. India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 60. India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 61. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 62. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 63. South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 64. South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 65. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 66. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 67. Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 68. Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 69. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 70. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 71. Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 72. Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 73. Middle East & Africa Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 74. Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Billion)
Table 75. Middle East & Africa Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)
Table 76. Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 77. UAE Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 78. UAE Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 79. UAE Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 80. UAE Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 81. Saudi Arabia: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 82. Saudi Arabia Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 83. Saudi Arabia Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 84. Saudi Arabia Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 85. South Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 86. South Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 87. South Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 88. South Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 89. Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 90. Rest of Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 91. Rest of Middle East & Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 92. Rest of Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 93. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).
Table 94. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 95. South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 96. South & Central America: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 97. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 98. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 99. Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 100. Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 101. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 102. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 103. Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 104. Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 105. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 106. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 107. Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 108. Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms
LIST OF FIGURES
Figure 1. Branded Generics Market Segmentation
Figure 2. Branded Generics Market, By Region
Figure 3. Global Branded Generics Market Overview
Figure 4. Others Segment Held Largest Share of Drug Class Segment in Branded Generics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Branded Generics Market, by Geography (US$ Million)
Figure 7. Global Branded Generics Market - Leading Country Markets (US$ Billion)
Figure 8. Global Branded Generics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints on Branded Generics Market
Figure 16. Global Branded Generics Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 17. Global Branded Generics Market – By Geography Forecast and Analysis – 2022 - 2028
Figure 18. Market Positioning of Key Players in Branded Generics Market
Figure 19. Global Branded Generics Market – Market Potential Analysis, By Region
Figure 20. Global Branded Generics Market – Comparative Company Analysis
Figure 21. Global Branded Generics Market – Growth Strategy Analysis
Figure 22. Market Share Analysis of Key Players in Global Branded Generics Market
Figure 23. By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)
Figure 24. Oncology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 25. Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 26. Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
Figure 27. Neurology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 28. Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 29. Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 30. Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
Figure 31. Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 32. Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 33. Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 34. Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 35. Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 36. Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 37. Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
Figure 38. Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 39. Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 40. Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 41. Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 42. Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 43. Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 44. Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 45. Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 46. Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 47. Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
Figure 48. Oral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 49. Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 50. Topical Market Revenue and Forecast to 2028 (US$ Billion)
Figure 51. Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 52. North America: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)
Figure 53. North America Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 54. North America: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 55. US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 56. Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 57. Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 58. Europe: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)
Figure 59. Europe: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 60. Europe: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 61. Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 62. France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 63. UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 64. Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 65. Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 66. Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 67. Asia Pacific Branded Generics Market Overview, by Country (2022)
Figure 68. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 69. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
Figure 70. Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 71. China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 72. India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 73. South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 74. Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 75. Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 76. Middle East & Africa: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)
Figure 77. Middle East & Africa Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 78. Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 79. UAE: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 80. SAudi Arabia: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 81. South Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 82. Rest of Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
Figure 83. South & Central America Branded Generics Market Overview, by Country (2022)
Figure 84. South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 85. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
Figure 86. Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 87. Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 88. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 89. Impact of COVID-19 Pandemic in North American Country Markets
Figure 90. Impact of COVID-19 Pandemic in European Country Markets
Figure 91. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 92. Impact of COVID-19 Pandemic in Middle East & African Country Markets
Figure 93. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 94. Growth Strategies Done by the Companies in the Market (%)
The List of Companies - Branded Generics Market
- MYLAN N.V.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- GlaxoSmithKline plc
- Bausch Health (Valeant Pharmaceuticals)
- Sandoz International Gmbh
- Aspen Holdings
- Par Pharmaceuticals
- Lupin
- Sanofi
- AstraZeneca
- Dr. Reddy's Laboratories Inc.
- Hetero
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Branded Generics Market
Jun 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)